UK Markets open in 2 hrs 9 mins
NIKKEI 225
28,099.77 +316.84 (+1.14%) HANG SENG
20,480.13 +171.00 (+0.84%) CRUDE OIL
74.40 +0.03 (+0.04%) GOLD FUTURES
1,998.40 +0.70 (+0.04%) DOW
32,859.03 +141.43 (+0.43%) BTC-GBP
22,738.54 -309.38 (-1.34%)
Alnylam Pharmaceuticals, Inc. (0HD2.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 03:02PM BST
| Previous close | 193.72 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 22.396B |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.55 |
| Earnings date | 26 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Why Is Allogene Therapeutics (ALLO) Down 19.4% Since Last Earnings Report?
Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Strength Seen in Halozyme Therapeutics (HALO): Can Its 5.3% Jump Turn into More Strength?
Halozyme Therapeutics (HALO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Business Wire
Alnylam Announces Appointment of Peter Kellogg to Board of Directors
CAMBRIDGE, Mass., March 08, 2023--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) the leading RNAi therapeutics company, announced today the appointment of Peter Kellogg to its Board of Directors. Mr. Kellogg is an accomplished industry executive with extensive global financial and strategic management experience.
© 2023 Yahoo. All rights reserved.
